ARCHIVES

NCI Offers Chlorozotocin

This article is from The Cancer Letter archive.

Vol. 03 No. 46 | November 18, 1977

Download PDF Visit The Full Archive

Related Articles

Chemoprevention Concept Approved By DCPC Bard Uses Biological Markers To Assess Risk Modulation

September 27, 1985

Proposed Deal Could Resolve Key Disputes At NSABP, Pitt

January 13, 1995

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

September 30, 2005

NIAID Advisors Ok Women & Infants Study Continuation

February 21, 1992

Opioid Pain Reliever Approved With Risk Reduction Plan

July 31, 2009

CCRAC Shoots Down Two Projects, Approves Others

December 15, 1978